Validating Novel Tau Positron Emission Tomography Tracer [F-18]-AV-1451 (T807) on Postmortem Brain Tissue
Overview
Authors
Affiliations
Objective: To examine region- and substrate-specific autoradiographic and in vitro binding patterns of positron emission tomography tracer [F-18]-AV-1451 (previously known as T807), tailored to allow in vivo detection of paired helical filament-tau-containing lesions, and to determine whether there is off-target binding to other amyloid/non-amyloid proteins.
Methods: We applied [F-18]-AV-1451 phosphor screen autoradiography, [F-18]-AV-1451 nuclear emulsion autoradiography, and [H-3]-AV-1451 in vitro binding assays to the study of postmortem samples from patients with a definite pathological diagnosis of Alzheimer disease, frontotemporal lobar degeneration-tau, frontotemporal lobar degeneration-transactive response DNA binding protein 43 (TDP-43), progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy, cerebral amyloid angiopathy and elderly controls free of pathology.
Results: Our data suggest that [F-18]-AV-1451 strongly binds to tau lesions primarily made of paired helical filaments in Alzheimer brains (eg, intraneuronal and extraneuronal tangles and dystrophic neurites), but does not seem to bind to a significant extent to neuronal and glial inclusions mainly composed of straight tau filaments in non-Alzheimer tauopathy brains or to lesions containing β-amyloid, α-synuclein, or TDP-43. [F-18]-AV-1451 off-target binding to neuromelanin- and melanin-containing cells and, to a lesser extent, to brain hemorrhagic lesions was identified.
Interpretation: Our data suggest that [F-18]-AV-1451 holds promise as a surrogate marker for the detection of brain tau pathology in the form of tangles and paired helical filament-tau-containing neurites in Alzheimer brains but also point to its relatively lower affinity for lesions primarily made of straight tau filaments in non-Alzheimer tauopathy cases and to the existence of some [F-18]-AV-1451 off-target binding. These findings provide important insights for interpreting in vivo patterns of [F-18]-AV-1451 retention.
F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.
Alosco M, Mejia Perez J, Culhane J, Shankar R, Nowinski C, Bureau S Mol Neurodegener. 2025; 20(1):23.
PMID: 39994806 PMC: 11852567. DOI: 10.1186/s13024-025-00808-1.
Rich A, Oh H bioRxiv. 2025; .
PMID: 39975208 PMC: 11838288. DOI: 10.1101/2025.01.27.635113.
PET Imaging of a Transgenic Tau Rat Model SHR24 with [F]AV1451.
Ramakrishnan N, Zhao A, Thompson S, Milicevic Sephton S, Williamson D, Smolek T Mol Imaging Biol. 2025; .
PMID: 39838233 DOI: 10.1007/s11307-024-01972-4.
Saez-Calveras N, Vaquer-Alicea J, White 3rd C, Tak Y, Cosentino S, Faust P Acta Neuropathol. 2025; 149(1):6.
PMID: 39775287 PMC: 11711841. DOI: 10.1007/s00401-024-02843-6.
Locus coeruleus tau is linked to successive cortical tau accumulation.
Yi D, Byun M, Jung J, Jung G, Ahn H, Chang Y Alzheimers Dement. 2024; 21(2):e14426.
PMID: 39641328 PMC: 11848382. DOI: 10.1002/alz.14426.